Post COVID-19 splenic infarction with limb ischemia: A case report

Hazhir Moradi1, Samah Mouzannar2, Seyed Amir Miratashi Yazdi3

  • 1Medical Student, Medical School, Isfahan University of Medical Sciences, Isfahan, Iran.

Insights

COVID-19 can cause rare splenic artery thrombosis, a serious condition. This case study highlights a patient successfully treated with heparin, showing thrombosis resolution post-infection.

Area of Science:

  • Vascular Medicine
  • Infectious Diseases
  • Radiology

Background:

  • COVID-19 is linked to thrombotic events, including pulmonary embolism and abdominal visceral infarctions.
  • Reported abdominal visceral infarctions include splenic, renal infarction, and intestinal ischemia.

Observation:

  • A 59-year-old female with COVID-19 presented with left upper quadrant pain and left heel discoloration.
  • Ultrasound revealed vein thrombosis; CT confirmed splenic infarction.
  • Malignancy and other causes were ruled out, attributing splenic infarction to SARS-CoV-2-induced coagulopathy.

Findings:

  • Splenic infarction, a rare complication of COVID-19, was diagnosed in a 59-year-old female patient.
  • Treatment with heparin infusion was initiated, followed by oral anticoagulants upon discharge.
  • Follow-up CT showed spleen size reduction with no clinical complications, indicating successful treatment.

Implications:

  • This case underscores the importance of considering rare thrombotic complications of COVID-19.
  • Early diagnosis and anticoagulation therapy are crucial for managing splenic infarction in COVID-19 patients.
  • Further research into the coagulopathic mechanisms of SARS-CoV-2 is warranted.
Abstract